Movetis was a pharmaceutical company headquartered in Belgium. It was founded in 2006 as a spin-off from parent company

Johnson & Johnson Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company i ...

. The company specialized in pharmaceuticals for treating gastro-intestinal disorders. The primary drug produced by Movetis was Prucalopride (known by the brand name "Resolor"), indicated for cases of chronic constipation.

History

Movetis was founded by Dirk Reyn, Staf Van Reet Jan schuurkes and Remi VandenBroek, and was backed by venture firms Sofinnova Partners, Sofinnova Ventures and Life Sciences Partners. In December 2009, it became a public company with an IPO on the New York Stock Exchange's Euronext. Shortly thereafter, it gained regulatory approval to distribute Resolor in 30 European countries. In 2010, the company was acquired by British drugmaker

Shire Shire is a traditional term for an administrative division of land in Great Britain and some other English-speaking countries such as Australia and New Zealand. It is generally synonymous with county. It was first used in Wessex from the beginn ...

Plc for 428 million euros ($559 million).Shire to buy Belgian drugmaker Movetis for $560mln
/ref>

References

{{reflist Johnson & Johnson subsidiaries Pharmaceutical companies of Belgium Pharmaceutical companies established in 2006 2010 mergers and acquisitions